CClinicalTrials.gg
RecruitingNCT05540613Updated Dec 11, 2024

Tai Chi Versus Conventional Exercise to Improve Cognitive Performance in Older Adults With Mild Cognitive Impairment

An interventional study of Health Education and Conventional Exercise in Mild Cognitive Impairment, sponsored by The University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2024-12-11.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started Nov 2022; still recruiting 3 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
315
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

This randomized controlled trial aims to evaluate the effectiveness of Tai Chi and conventional exercise on improving cognitive function in older adults with mild cognitive impairment (MCI). Participants will be randomized into three six-month programmes, namely Health Education group, Tai Chi group and Conventional Exercise group. Assessments will be conducted at baseline, after the 26-week interventions, and 26-week after the competition of the intervention.

02

Conditions studied

  • Mild Cognitive Impairment
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's planned enrollment of 315 is above the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Chinese older adults aged equal or larger than 50 years
  • Ethnic Chinese
  • MCI under criteria of Mayo Clinic, including the following

    i. people with subjective complaint about a decline in cognitive function. ii. total score in the Montreal Cognitive Assessment is equal or below the 7th percentile of the age- and education- corrected normative data of Hong Kong. iii. the decline in cognitive function does not impair daily functioning, as revealed by getting ≥2 marks in every item on the Chinese Lawton Instrumental Activities of Daily Living 4-point Scale).

Exclusion criteria

Exclusion Criteria:

  • medical history of major chronic diseases such as cancer, stroke, cerebro- and cardio-vascular diseases, and renal disease
  • uncontrolled diabetes
  • diagnosed with dementia or using anti-dementia medication
  • diagnosed with psychiatric diseases or using psychiatric medication
  • with diseases or on medications known to severely affect cognitive performance
  • somatic condition (e.g., limb lost) that prevent participation in exercise
  • impaired mobility by chronic diseases (e.g., neurological, musculoskeletal and autoimmune diseases)
  • incapable to perform physical exercise
  • regular exercise habit (>3 times 60-min Tai Chi or moderate-intensity conventional exercise weekly) in the past 3 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
315 participants (estimated)

Study arms

  • Sham comparator
    Health Education

    A 26 weeks brain health and general health education program with two 1.5-hour sessions weekly.

    Behavioral: Health Education

  • Active comparator
    Conventional Exercise

    A 26 weeks Conventional Exercise training with two 1.5-hour sessions weekly.

    Behavioral: Conventional Exercise

  • Experimental
    Tai Chi

    A 26 weeks Tai Chi training with two 1.5-hour sessions weekly.

    Behavioral: Tai Chi

Interventions

  • BehavioralHealth Education

    A 26 weeks brain health and general health education program with two 1.5-hour sessions weekly.

  • BehavioralConventional Exercise

    A 26 weeks Conventional Exercise training with two 1.5-hour sessions weekly.

  • BehavioralTai Chi

    A 26 weeks Tai Chi training with two 1.5-hour sessions weekly.

06

What researchers measure

Primary outcomes

  1. The score of the Montreal Cognitive Assessment (MoCA)

    Change in the score of the Montreal Cognitive Assessment. The score ranged from 0 to 30. Higher score indicates a better cognitive function. Participants scoring equal or below the 7th percentile of the age- and education-corrected normative data will be considered as having MCI.

    Time frame: 26 weeks

  2. The score of the Montreal Cognitive Assessment (MoCA)

    Change in the score of the Montreal Cognitive Assessment. The score ranged from 0 to 30. Higher score indicates a better cognitive function. Participants scoring equal or below the 7th percentile of the age- and education-corrected normative data will be considered as having MCI.

    Time frame: 52 weeks

Secondary outcomes

  1. Clinical Dementia Rating

    The Clinical Dementia Rating (CDR) is a numeric scale of 0-3 points based on clinician/ certified rater ratings of cognition and daily function in the domains of memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. Rating from 0, 0.5, 1, 2 and 3 indicated subjects' cognitive function having healthy, very mild impairment, mild impairment, moderate impairment and severe impairment respectively.

    Time frame: 26 weeks and 52 weeks

  2. Neurocognitive Test

    The NIH Toolbox Cognitive Function Battery (CFB) will be used to objectively evaluate the various cognitive domains. CFB assesses cognitive abilities in different cognitive domains, including memory, executive function and attention. CFB will be delivered on a tablet computer.

    Time frame: 26 weeks and 52 weeks

  3. Subjective Cognitive Performance

    The Cognitive Self-Report Questionnaire (CSRQ) will be used to examine the subjective cognitive performance. The CSRQ is validated in Hong Kong and comprises 25 questions with an overall score ranging from 0-100. A higher score indicates worse self-perception on cognitive performance.

    Time frame: 26 weeks and 52 weeks

  4. Subjective Memory complaints

    The memory inventory for the Chinese - a questionnaire exploring subjective memory complaints and the effects on daily activities - will be performed to examine the subjective memory complaints.

    Time frame: 26 weeks and 52 weeks

  5. Subjective Sleep Quality

    The Pittsburgh Sleep Quality Index (PSQI) will be used to assess sleep quantity and the perceived restfulness and disturbance of sleep by gathering information on usual bed time, wake time, time to fall asleep, time of actual sleep, and quality of sleep. Each item is rated on a "0-3" Likert scale, with a higher score indicating poorer sleep quality.

    Time frame: 26 weeks and 52 weeks

  6. The Hospital Anxiety and Depression Scale

    The Hospital Anxiety and Depression Scale assesses the severity of depression and anxiety. This 14-item questionnaire has subscales for both depression and anxiety and the overall score ranges from 0-21, with a higher score indicating more severe depressive/anxious symptoms.

    Time frame: 26 weeks and 52 weeks

  7. The 12-Item Short Form Survey

    The 12-Item Short Form Survey measures health-related quality of life. It has 12 items assessing physical functioning, emotional and mental health, bodily pain, general health, vitality, and social functioning, with higher overall scores indicating a better quality of life.

    Time frame: 26 weeks and 52 weeks

  8. Medication Use

    Subjects' use of medications, unrelated to dementia and psychiatric conditions (e.g., sleep, dyslipidemic and hypertensive pills) will be recorded along with detailed usage information. Data on medication dose and weekly frequency will be presented as the total number of lowest recommended dose in 7 days for the analysis.

    Time frame: 26 weeks and 52 weeks

  9. Short Physical Performance Battery (SPPB) Test

    Physical function and balancing performance will be assessed using the Short Physical Performance Battery (SPPB). The SPPB involves repeated timed chair stands, timed standing balance (with feet in parallel in semi-tandem and tandem positions), and a 4-meter walk to measure the usual gait speed.

    Time frame: 26 weeks and 52 weeks

  10. Habitual Physical Activity

    Actigraph/IPAQ method to monitor and record habitual physical activity. Actigraph activity monitor (wGT3X-BT or GT9X, Actigraph, USA), a 3-axis accelerometer, will be used to objectively determine the habitual daily physical movement/activities.

    Time frame: 26 weeks and 52 weeks

07

Study locations

1 of 1 sites recruiting
  • The University of Hong Kong
    Hong Kong, 00, Hong Kong
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05540613
Lead sponsor
The University of Hong Kong
Responsible party
Sponsor
First posted
Sep 14, 2022
Start date
Nov 1, 2022
Primary completion
Jan 2025 (estimated)
Completion
Jan 2026 (estimated)
Last update
Dec 11, 2024

Study contacts

Pak Hung Yu, PhD
Contact
aphyu@connect.hku.hk
67533806
Parco Siu, PhD
Contact
Parco Siu, PhD
principal investigator · The University of Hong Kong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion